The FDA has expanded eligibility for the new Covid-19 boosters to children as young as 5 years old
U.S. health regulators on Wednesday expanded eligibility for the new Covid-19 booster shots to children as young as 5 years old, broadening access to help bolster protection against Omicron strains of the coronavirus.
The U.S. Food and Drug Administration authorized the updated booster from Pfizer Inc. and its partner BioNTech SE for
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
FDA authorizes omicron-targeting COVID-19 booster for younger kidsThe Food and Drug Administration authorized the bivalent COVID-19 booster shot for younger children. Moderna's booster is authorized for children six years and older.
続きを読む »
Covid-19 Boosters Targeting Omicron Authorized for Kids as Young as 5The FDA’s decision broadens a campaign by health officials to bolster protection against the Omicron strains of the coronavirus.
続きを読む »
US clears updated COVID boosters for kids as young as 5Kids as young as 5 can soon get updated COVID-19 booster shots
続きを読む »
US clears updated COVID boosters for kids as young as 5The Centers for Disease Control and Prevention, which recommends how vaccines are used, also signed off.
続きを読む »
FDA authorizes COVID-19 Omicron booster for kidsThe booster shots are now authorized for children as young as 5 years old.
続きを読む »